December 23, 2008 — In the treatment of advanced ovarian cancer, neoadjuvant chemotherapy before surgical debulking may be the new standard of care — especially in countries where the scheduling of a ...

The involvement of 2 surgeons during cytoreductive debulking and bowel surgery in patients with epithelial ovarian cancer significantly reduces the rate of anastomotic leaks. In hopes of achieving ...

Significant disparities exist in the adoption of minimally invasive interval debulking surgery for advanced ovarian cancer, with gaps potentially widening as the procedure becomes more common.

Effect of nilotinib on cell proliferation and migration of ovarian cancer cells alone and in combination with standard chemotherapy. Background: Advances in laparoscopic surgery have allowed a ...

Debulking surgery is generally the next step after neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer, but there has been controversy as to whether women should undergo a ...

Patients with advanced ovarian cancer who achieved complete cytoreduction had the best outcomes, regardless of the number of chemotherapy cycles before surgery. Increasing the number of chemotherapy ...

A retrospective review of New Zealand patients with advanced ovarian cancer treated with dose dense chemotherapy. Lymph node involvement pattern and survival differences of FIGO IIIC[1] and FIGO IIIA1 ...

Please provide your email address to receive an email when new articles are posted on . Laparoscopy may have some advantages over laparotomy for ovarian cancer. Results of this review are limited and ...